Combination therapy to increase endogenous nitric oxide (no) synthesis
AssigneeYeda Research and Development Co. Ltd.
InventorsAyelet EREZ, Noa STETTNER
Life of this patent
Estimating the term…
Abstract
Provided are uses of a therapeutically effective amount of citrulline for the manufacture of a medicament for treatment of a subject having an inflammatory bowel disease (IBD) and/or colon cancer. Also provided are pharmaceutical compositions comprising a therapeutic effective amount of citrulline and a therapeutically effective amount of a flavonoid for the treatment of an inflammatory bowel disease (IBD) and/or colon cancer and kits comprising same.
Claims18
(canceled)
A method of treating inflammatory bowel disease (IBD) and/or colon cancer comprising administering to a subject in need thereof a therapeutically effective amount of citrulline and a therapeutically effective amount of a flavonoid, thereby treating the subject.
A pharmaceutical composition comprising a therapeutic effective amount of citrulline and a therapeutically effective amount of a flavonoid for the treatment of an inflammatory bowel disease (IBD) and/or colon cancer.
(canceled)
Dependencies are inferred from the claim text.